Atlas Trials

Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol

Clinical trial NCT01537692 · COMPLETED

Trial details

NCT number
NCT01537692
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2009-03-01
Primary completion
2009-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.